Annals of Surgical Oncology

, Volume 20, Issue 8, pp 2759–2764

Robotic Single-site Hysterectomy in Low Risk Endometrial Cancer: A Pilot Study

  • Enrico Vizza
  • Giacomo Corrado
  • Emanuela Mancini
  • Ermelinda Baiocco
  • Lodovico Patrizi
  • Luana Fabrizi
  • Luca Colantonio
  • Monica Cimino
  • Stefano Sindico
  • Ester Forastiere
Gynecologic Oncology

DOI: 10.1245/s10434-013-2922-9

Cite this article as:
Vizza, E., Corrado, G., Mancini, E. et al. Ann Surg Oncol (2013) 20: 2759. doi:10.1245/s10434-013-2922-9

Abstract

Background

To evaluate the feasibility and the safety of robotic single-site hysterectomy (RSSH) in low risk early endometrial cancer.

Methods

Patients with clinical low risk early endometrial cancer were enrolled onto a prospective cohort trial. All surgical procedures were performed through a single 2–2.5 cm umbilical incision, with a multichannel system consisting of a five-lumen port providing access for two single-site instruments (da Vinci Si Surgical System, Intuitive Surgical, Sunnyvale, CA), the 8.5 mm 3D HD endoscope, a 5/10 mm accessory port, and an insufflation adaptor.

Results

Between December 2011 and June 2012, a total of 17 patients were included in our pilot study. The median age of the patients was 64 years (range, 42–84 years), and median body mass index was 26.6 kg/m2 (range, 18–52 kg/m2). One patient was excluded from the study as a result of pelvic metastasis during inspection of abdominal cavity, and another patient was converted to vaginal surgery as a result of problems of hypercapnia. The median docking time, console time, and total operative time was 8 min (range, 5–14 min), 48 min (range, 45–51 min), and 90 min (range, 70–147 min), respectively. The median blood loss was 75 mL (range, 50–150 mL). No laparoscopy/laparotomy conversion was registered. The median time to discharge was 2 days (range, 1–3 days). Neither intraoperative nor postoperative complications occurred. At a median of 7.5 months’ follow-up, all patients were disease-free.

Conclusions

RSSH is technically feasible in patients affected by low risk early endometrial cancer. Additional studies with gynecologic oncologic cases should be performed to explore the possible benefits of RSSH.

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • Enrico Vizza
    • 1
  • Giacomo Corrado
    • 1
  • Emanuela Mancini
    • 1
  • Ermelinda Baiocco
    • 1
  • Lodovico Patrizi
    • 2
  • Luana Fabrizi
    • 3
  • Luca Colantonio
    • 3
  • Monica Cimino
    • 1
  • Stefano Sindico
    • 1
  • Ester Forastiere
    • 3
  1. 1.Gynecologic Oncologic Unit, Department of Oncological Surgery“Regina Elena” National Cancer InstituteRomeItaly
  2. 2.Section of Gynecology, Academic Department of Biomedicine and Prevention and ClinicalTor Vergata UniversityRomeItaly
  3. 3.Anesthesia Unit, Department of Intensive Care, Pain Therapy and Palliative Care“Regina Elena” National Cancer InstituteRomeItaly